Listing claim matches the Supplement Facts panel
What is advertised is what the label declares. This checks internal consistency; it is not an independent test of the contents.

Listing claim matches the Supplement Facts panel
Rebuilt from public sources on July 23, 2026 · evidence availability is not a safety or effectiveness verdict.
What is advertised is what the label declares. This checks internal consistency; it is not an independent test of the contents.
You can compare each declared dose with research instead of guessing what is hidden inside a blend.
Use the linked research to check whether the ingredient and outcome you care about are actually connected. Ingredient evidence does not verify this product.
Only product facts and comparisons earn a card. Pipeline gaps stay collapsed.
The listing claims 1 g; the photo-read Supplement Facts panel shows NMN at 1 g per serving — the listing text and its photo-read panel agree; this is internal consistency, not independent testing.
Why it mattersWhat is advertised is what the label declares. This checks internal consistency; it is not an independent test of the contents.
Open the source-linked findingThe panel gives a per-ingredient amount rather than hiding quantities inside a proprietary blend, so each one can be compared to published research.
Why it mattersYou can compare each declared dose with research instead of guessing what is hidden inside a blend.
Open the source-linked findingPublished sources describe how NMN have been studied. This is ingredient context only; the record does not establish that this product delivers the studied dose or outcome. Sources: PubMed search: nicotinamide mononucleotide human trial, ClinicalTrials.gov — NMN.
Why it mattersUse the linked research to check whether the ingredient and outcome you care about are actually connected. Ingredient evidence does not verify this product.
Open the source-linked findingThese are evidence gaps, not strikes against the product.
These links provide the public research context used alongside the captured panel. They do not establish safety, effectiveness, or product quality.
The summary stops at product-specific facts. The full report preserves every source, calculation, limitation, and unresolved check for review or sharing.
Confirmed evidence
These checks found support in the public record. They confirm specific facts, not the product as a whole.
label claims 1000 mg/serving — within the range commonly used in research (human trials to date mostly use 250–1,000 mg/day). Sources: PubMed search: nicotinamide mononucleotide human trial, ClinicalTrials.gov — NMN.
The panel gives a per-ingredient amount rather than hiding quantities inside a proprietary blend, so each one can be compared to published research.
Documented concerns
These are documented contradictions or claims that need more evidence. They are separate from missing data.
No contradictions or product-specific cautions were found at this check depth.
Unresolved public record
We looked for these signals but could not settle them from public sources. A gap is not a strike.
The listing claims 1 g; the photo-read Supplement Facts panel shows NMN at 1 g per serving — the listing text and its photo-read panel agree; this is internal consistency, not independent testing.
Published sources describe how NMN have been studied. This is ingredient context only; the record does not establish that this product delivers the studied dose or outcome. Sources: PubMed search: nicotinamide mononucleotide human trial, ClinicalTrials.gov — NMN.
The NIH Dietary Supplement Label Database has no matching label yet. Ingestion lags the market — recorded as a gap, not a strike.
The paid catalog links this exact item to a parent listing. Review counts on public product pages may be shared across sizes, flavors, or other variants, so the count history is listing context — not evidence that reviewers received or tested this exact variant.
Exact-listing history records written-review counts from 19 on 2026-01-31 to 110 on 2026-07-14 (net +91). Count movements can reflect sales, listing variants, collection resets, or moderation; this history does not establish whether reviews are authentic.
Check digit passes; no third-party database record found yet. Coverage gaps are common — not a strike.
What to ask and check
Ask the brand or seller
Answered by the panel: 1 g of the 1 g headline is nmn. Which independent lab can confirm that amount in this product?
The panel resolves the front-label arithmetic. The remaining question is lot-specific contents and stability; published category testing gives context, not a test of this product.
Is this label filed with NIH’s Dietary Supplement Label Database (DSLD)?
Filing is voluntary, so absence proves nothing — but a filed label puts the full ingredient table on public record where anyone can read it.
Most brands and sellers publish a contact route. A clear answer adds evidence to the record; no answer leaves the question open.
Check for yourself — no one’s permission needed
Compare the panel on the bottle in your hand to the one shown in this record.
Ours was read from listing photos and can contain reading errors. The physical label is the source of truth — if they disagree, tell us and we’ll correct the record.
Scan the barcode on the package and confirm it reads 739768820000.
A mismatch between the barcode on the box and the one on the listing is worth pausing over — it can indicate a different variant, a repack, or a counterfeit.
Check the lot number and expiry on the bottle against any COA you’re given.
A certificate that doesn’t name your lot doesn’t describe what you’re holding.
These are the open questions on this specific record — not a warning about the product, and not a suggestion to buy or avoid it. Getting them answered is how you decide for yourself.
Record built July 23, 2026. Sources: source listing observed at check time · USPTO Trademark Search · Keepa exact-listing history · NIH / published research · certification and regulator records where available. LookCloser publishes evidence and gaps; it does not advise for or against any supplement. Evidence-based corrections welcome.